Skip to content

DR. BARTH JOERI

Active
Private limited companyfounded 2019active for 7 yearsTen Hove 8, 8200 Brugge, BelgiumKBO/BCE: BE 0720.802.050
Summary

DR. BARTH JOERI has been active since 2019 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €307,457 and a net result of €283,006. Equity is growing by about 34% per year across the filed financial years. Its solvency ranks better than 22% of 2,957 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Overview

Activity
Specialist medical practice
NACE 86220
1 site
Size
€1.4mtotal assets 2025
Equity
€307,457
Profit
€283,006
Turnover not published (abbreviated or micro format)
Financial health
88 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.1%
Structure
Accounts filed 54 days late0 of 2 deeds read
Why 88raises riskLatest accounts 54 days late; 3 of the last 3 latelowers riskSector: Human health activities (NACE 86)Size: total assets €1.4mFigures for financial year 2025 (filed 21-09-2026)Show the evidence

Checked score

Score 2025
88 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 21% of its sector peers (NACE 86, micro)
Financial strength · tick = 2024
Average
Solvency 47-53
equity 21.7% of total assets
Liquidity 21-48
short-term debt 65.8% · cash 4.8%
Profitability 94=
return on assets 19.9%
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

About 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,058 companies, NACE 86, micro)
Last 24 months 11-2024: 0.1% 12-2024: 0.1%● unchanged vs 11-2024 01-2025: 0.1%● unchanged vs 12-2024 02-2025: 0.1%● unchanged vs 01-2025 03-2025: 0.1%● unchanged vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025 05-2025: 0.1%● unchanged vs 04-2025 06-2025: 0.1%● unchanged vs 05-2025 07-2025: 0.1%● unchanged vs 06-2025 08-2025: 0.2%▲ +0.1 percentage points vs 07-2025 09-2025: 0.3%▲ +0.1 percentage points vs 08-2025highest value 10-2025: < 0.1%▼ -0.3 percentage points vs 09-2025lowest value 11-2025: < 0.1%● unchanged vs 10-2025lowest value 12-2025: < 0.1%● unchanged vs 11-2025lowest value 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: 0.1%▲ +0.1 percentage points vs 06-2026 08-2026: 0.1%● unchanged vs 07-2026 09-2026: 0.2%▲ +0.1 percentage points vs 08-2026 10-2026: 0.1%▼ -0.1 percentage points vs 09-2026
Credit of up to €25,000 on 30-day terms is acceptable
Liquidity insufficient (current ratio 0.61, compared with 5.58 in 2024, below 1; short-term debt: 65.8% and cash: 4.8% of total assets), and 78.3% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 21% on solvency, 3% on liquidity, 52% on profitability and 7% on growth.

The bankruptcy probability was computed on 15-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
raises risk · Latest accounts 54 days late; 3 of the last 3 late
NBB · filings
lowers risk · Size: total assets €1.4m
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed 21-09-2026)
NBB · annual accounts
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 22% of 2957 sector peers (2025).
NBB · sector comparison
Position among 2957 sector peers
Solvency
better than 22%
← weakest strongest →
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 23-09-2026, 54 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 7 filings
Deviation from the deadline
2025
54 days late
2024
61 days late
2023
68 days late
2022
69 days late
2021
33 days late
2020
61 days late
2019
110 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 65 days after the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 30 September (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
16-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · abbreviated…
  2. Annual accounts filedfinancial year 2024 · micro…
  3. Highest result from 2019 to 2025net €361,268 ▲26.7%

Key points

  • Caution: Equity fell in 2025from €1.4m to €307,457 ▼ 78.4% View
  • Positive: 7 profitable years in a rowprofit 2025: €283,006 7 years View
  • Total assets 20256 financial years filed €1.4m View

By topic

Financials

Financial year
2025
Total assets
€1.4m
Profit
€283,006
Solvency
21.7%
Total assets▼ 21.4%
Net result
20192025
Go to Financials

Timeline

Events
11
Since
2020
Next accounts
by 31-07-2027
  1. 07-10-2024Annual accounts filed
  2. 31-12-2023Equity above €1m
  3. 08-10-2023Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Specialist medical practiceNACE 86220
Founded
15-02-2019
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.